ESMO 2022 Conference Coverage
Lecture Summary - ESMO 2022 on the DAISY Trial: Antitumor Activity of T-DXd in Patients With mBC and Brain Metastases
By
ESMO 2022 Conference Coverage
FEATURING
Nicolas Epaillard
By
ESMO 2022 Conference Coverage
FEATURING
Nicolas Epaillard
Login to view comments.
Click here to Login
